Monash University Handbook 2010 Postgraduate - Unit
DPSY6105 - Psychopharmacology
0 points, SCA Band 1, 0.000 EFTSL
Synopsis
The unit will cover the following topics.
Introduction to drug classifications; legal control of drug use; pharmacokinetics; variability in response to drugs; chemical transmission and receptors.
Mood disorders: antidepressants and mood stabilizers; anti-anxiety drugs, sedatives and hypnotics, drugs used for OCD, panic, and phobic disorders. Psychosis and schizophrenia; anti-psychotic drugs. Cognitive enhancers: ADHD, Alzheimer's disease, brain trauma.
Drugs of abuse: affects on brain and cognition.
Objectives
On completion of the unit students should:
- Understand the basic concepts of psychopharmacology with particular reference to recent advances in the fields of psychiatric medication, cognitive enhancers and neuroprotective agents, and substance abuse;
- Have a broad understanding of commonly prescribed psychoactive drugs, legal and illegal drugs and other commonly abused substances.
- Be able to comment on the likely physiological and psychological effects in a particular individual of a specific drug (together with possible drug interactions), and to prepare a written report on the topic.
- Be exposed to current issues in clinical psychopharmacology and in research concerning treatment approaches.
Assessment
Satisfactory attendance and participation are required to pass the unit. All other components of assessment must attain a pass standard at least. The assessment tasks will include a short answer take-home exam, class presentation, and a written paper.
Chief examiner(s)
Dr Jillian Broadbear